Drug company seeks to suppress internal memos.
Lenzer
Jeanne
J
D014150:Antipsychotic Agents / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D003920:Diabetes Mellitus / Q000139:chemically induced; D004282:Documentation; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D000077152:Olanzapine; D010330:Patents as Topic; D014481:United States
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine